Diabetes Mellitus is one of the World Health Organization's priority diseases under research by first and second programmes Innovative Medicines Initiative, with acronyms IMI1 IMI2, respectively. Up to October 2019, 13 projects were funded IMI for & Metabolic disorders, namely SUMMIT, IMIDIA, DIRECT, StemBANCC, EMIF, EBiSC, INNODIA, RHAPSODY, BEAT-DKD, LITMUS, Hypo-RESOLVE, IM2PACT, CAR...